Market News AIOpen the app

Lyell Immunopharma is letting stockholders sell 7.43 million shares of its common stock.

New sharesRead the original at streetinsider.com
Bad for LYEL

LYEL registered 7.43 million existing shares for sale by current owners. Lyell gets no cash, and the shares becoming available for sale may weigh on its stock.

LYEL · Lyell Immunopharma, Inc.

AI read · Bad for LYEL

The AI's read

The shares belong to current owners, so the filing does not bring cash into Lyell or add newly issued shares. It does make existing shares available for sale, which may weigh on the stock.

Get alerts for LYEL

Follow Lyell Immunopharma, Inc. (LYEL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LYEL
Free on the App Store and Google Play, or on the web.